Shared decision-making (SDM) has been called the “pinnacle of patient-centered care” and shown to increase patient satisfaction, reduce decisional conflict, and improve care outcomes. However, less is known about the impact of SDM on health care costs and utilization, as well as potential unintended consequences of SDM. Does SDM reduce low-value care, or is it in and of itself low-value care?
During an issue panel presentation at the 2020 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Virtual Conference, Discern Health Vice President Theresa Schmidt and colleagues from the National Pharmaceutical Council (NPC), Moffitt Cancer Center, and Patient Advocate Foundation debated this question and other controversies of SDM. This presentation builds off a systematic review that Discern and NPC are conducting on the impact of SDM on health care costs and utilization.
Learn about SDM and key points from the panel in The Evidence Base®.